Minesh Patel
Child & Adolescent Psychiatry · Dobbs Ferry, NYNPI 1033409073
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 571 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by AbbVie at 24.8% of the total. Among child & adolescent psychiatry clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 571 payments — averaging $19.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Corium, LLC$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Otsuka America Pharmaceutical, Inc.$855
- Sunovion Pharmaceuticals Inc.$814
- Abbott$772
- plus $3K from 19 others
What the payments were for
- Food & beverage$11,301100%
- Education$420%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 161 | $2,816 |
| Corium, LLC | 86 | $1,341 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 57 | $1,288 |
| Otsuka America Pharmaceutical, Inc. | 38 | $855 |
| Sunovion Pharmaceuticals Inc. | 41 | $814 |
| Abbott | 19 | $772 |
| Neurocrine Biosciences, Inc. | 26 | $589 |
| Tris Pharma Inc | 30 | $449 |
| Lundbeck LLC | 19 | $447 |
| Takeda Pharmaceuticals U.S.A., Inc. | 20 | $416 |
| Supernus Pharmaceuticals, Inc. | 13 | $241 |
| Axsome Therapeutics, Inc. | 9 | $238 |
| Teva Pharmaceuticals USA, Inc. | 9 | $203 |
| Johnson & Johnson | 9 | $187 |
| Shire North American Group Inc | 6 | $112 |
| Ironshore Pharmaceuticals Inc. | 4 | $96 |
| Collegium Pharmaceutical, Inc. | 4 | $91 |
| Arbor Pharmaceuticals, Inc. | 5 | $90 |
| Adlon Therapeutics L.p. | 5 | $87 |
| Vertical Pharmaceuticals, LLC | 3 | $61 |
| Alkermes, Inc. | 2 | $48 |
| Jazz Pharmaceuticals Inc. | 2 | $34 |
| Almatica Pharma LLC | 1 | $23 |
| Avion Pharmaceuticals | 1 | $23 |
| Indivior Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,343 in reported general payments places this provider in the 95th percentile of 317 child & adolescent psychiatry providers in New York.
See all child & adolescent psychiatry providers in New York →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 12 | $84,760 |
| Lamotrigine ErLamotrigine | 11 | $3,575 |
| Bupropion XlBupropion Hcl | 19 | $697 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 12 | $439 |
| Trazodone Hcl | 33 | $343 |
| Bupropion Hcl SrBupropion Hcl | 11 | $325 |
| Sertraline Hcl | 31 | $135 |
| Gabapentin | 12 | $74 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $589 | $84,76012 claims |
| Almatica Pharma LLCSertraline Hcl | $23 | $13531 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 317 child & adolescent psychiatry providers in New York.
Other child & adolescent psychiatry in Dobbs Ferry
- Matthew LorberNew York$398K
- Mitchell CabisudoNew Windsor$346K
- Parinda ParikhWhite Plains$185K
- Jeffrey NewcornNew York$165K
- John MarinoCanandaigua$70K
- Iliyan IvanovNew York$38K
- Melvin OatisNew York$35K
- Vijay PampanaMiddletown$19K
- Marc ReitmanHuntington$13K
- Marie CharlesBrooklyn$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.